| abstract |
At least one of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA (n-3) or DPA (n-6)), eicosatetraenoic acid and arachidonic acid (ARA) A composition for treating two deficiencies is provided. EPA, DHA, DPA (n-3) or DPA (n-6), eicosatetraenoic acid and ARA derived from genetically modified seeds and marine organisms (including fish and squid) Production and use of fractions rich in polar lipids, especially extraction, separation, synthesis and recovery. As well as their use in human food applications, animal feeds, pharmaceutical applications and cosmetic applications. [Selection figure] None |